Aβ43 is neurotoxic and primes aggregation of Aβ40 in vivo

Acta Neuropathologica

Volumn 130, Issue 1, 2015, Pages 35-47

  Burnouf, Sylvie ^a,b   Gorsky, Marianna Karina ^a,b   Dols, Jacqueline ^a,b   Grönke, Sebastian ^a,b   Partridge, Linda ^a,b,c  

^a MAX PLANCK INSTITUTE FOR BIOLOGY OF AGEING   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer s disease; Amyloid ; Drosophila models; Neurodegeneration; Neurotoxicity

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-43]; UNCLASSIFIED DRUG; AMYLOID BETA-PROTEIN (1-42); AMYLOID BETA-PROTEIN (1-43); MESSENGER RNA; PEPTIDE FRAGMENT; PROTEIN AGGREGATE;

ADULT; ADULT ANIMAL; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CELL SURVIVAL; CLIMBING; CONTROLLED STUDY; FEMALE; FRUIT FLY MODEL; HUMAN; IN VIVO STUDY; LIFESPAN; LOCOMOTION; MOLECULAR PATHOLOGY; MOTOR DYSFUNCTION; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PATHOGENICITY; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TRANSGENIC DROSOPHILA; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; DROSOPHILA; GENETICS; HEAD; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PHYSIOLOGY; SOLUBILITY; SURVIVAL ANALYSIS; TRANSGENIC ANIMAL;

AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DROSOPHILA; FEMALE; HEAD; MOTOR ACTIVITY; PEPTIDE FRAGMENTS; PHOTORECEPTOR CELLS, INVERTEBRATE; PROTEIN AGGREGATES; RNA, MESSENGER; SOLUBILITY; SURVIVAL ANALYSIS;

EID: 84931005949     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-015-1419-y     Document Type: Article

References (38)

1. Barucker C, Harmeier A, Weiske J, Fauler B, Albring KF, Prokop S et al (2014) Nuclear translocation uncovers the amyloid peptide Abeta42 as a regulator of gene transcription. J Biol Chem 289:20182–20191. doi:10.1074/jbc.M114.564690
2. Benilova I, Karran E, De Strooper B (2012) The toxic Abeta oligomer and Alzheimer’s disease: an emperor in need of clothes. Nat Neurosci 15:349–357. doi:10.1038/nn.3028
3. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB (2003) Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci USA 100:330–335. doi:10.1073/pnas.222681699
4. Conicella AE, Fawzi NL (2014) The C-terminal threonine of Abeta43 nucleates toxic aggregation via structural and dynamical changes in monomers and protofibrils. Biochemistry 53:3095–3105. doi:10.1021/bi500131a
5. Cowan CM, Shepherd D, Mudher A (2010) Insights from Drosophila models of Alzheimer’s disease. Biochem Soc Trans 38:988–992. doi:10.1042/BST0380988
6. Crowther DC, Kinghorn KJ, Miranda E, Page R, Curry JA, Duthie FA et al (2005) Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s disease. Neuroscience 132:123–135. doi:10.1016/j.neuroscience.2004.12.025
7. Finelli A, Kelkar A, Song HJ, Yang H, Konsolaki M (2004) A model for studying Alzheimer’s Abeta42-induced toxicity in Drosophila melanogaster. Mol Cell Neurosci 26:365–375. doi:10.1016/j.mcn.2004.03.001
8. Franceschini N, Kirschfeld K, Minke B (1981) Fluorescence of photoreceptor cells observed in vivo. Science 213:1264–1267
9. Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA 100:4078–4083. doi:10.1073/pnas.0737556100
10. Hao LY, Giasson BI, Bonini NM (2010) DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function. Proc Natl Acad Sci USA 107:9747–9752. doi:10.1073/pnas.0911175107
11. Iijima K, Chiang HC, Hearn SA, Hakker I, Gatt A, Shenton C et al (2008) Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila. PLoS ONE 3:e1703. doi:10.1371/journal.pone.0001703
12. Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, Zhong Y (2004) Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer’s disease. Proc Natl Acad Sci USA 101:6623–6628. doi:10.1073/pnas.0400895101
13. Iizuka T, Shoji M, Harigaya Y, Kawarabayashi T, Watanabe M, Kanai M et al (1995) Amyloid beta-protein ending at Thr43 is a minor component of some diffuse plaques in the Alzheimer’s disease brain, but is not found in cerebrovascular amyloid. Brain Res 702:275–278
14. Jackson GR, Salecker I, Dong X, Yao X, Arnheim N, Faber PW et al (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21:633–642
15. Jarrett JT, Berger EP, Lansbury PT Jr (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer’s disease. Biochemistry 32:4693–4697
16. Kayed R, Glabe CG (2006) Conformation-dependent anti-amyloid oligomer antibodies. Methods Enzymol 413:326–344. doi:10.1016/S0076-6879(06)13017-7
17. Keller L, Welander H, Chiang HH, Tjernberg LO, Nennesmo I, Wallin AK et al (2010) The PSEN1 I143T mutation in a Swedish family with Alzheimer’s disease: clinical report and quantification of Abeta in different brain regions. Eur J Hum Genet 18:1202–1208. doi:10.1038/ejhg.2010.107
18. Lesne SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, Bennett DA et al (2013) Brain amyloid-beta oligomers in ageing and Alzheimer’s disease. Brain 136:1383–1398. doi:10.1093/brain/awt062
19. Luheshi LM, Tartaglia GG, Brorsson AC, Pawar AP, Watson IE, Chiti F et al (2007) Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity. PLoS Biol 5:e290. doi:10.1371/journal.pbio.0050290
20. Markstein M, Pitsouli C, Villalta C, Celniker SE, Perrimon N (2008) Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes. Nat Genet 40:476–483. doi:10.1038/ng.101
21. McLaurin J, Kierstead ME, Brown ME, Hawkes CA, Lambermon MH, Phinney AL et al (2006) Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nat Med 12:801–808. doi:10.1038/nm1423
22. Meli G, Lecci A, Manca A, Krako N, Albertini V, Benussi L et al (2014) Conformational targeting of intracellular Abeta oligomers demonstrates their pathological oligomerization inside the endoplasmic reticulum. Nat Commun 5:3867. doi:10.1038/ncomms4867
23. Meng P, Yoshida H, Tanji K, Matsumiya T, Xing F, Hayakari R et al (2014) Carnosic acid attenuates apoptosis induced by amyloid-beta 1-42 or 1-43 in SH-SY5Y human neuroblastoma cells. Neurosci Res. doi:10.1016/j.neures.2014.12.003
24. Mizielinska S, Grönke S, Niccoli T, Ridler C, Clayton E, Devoy A et al (2014) C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 345:1192–1194
25. Morais VA, Haddad D, Craessaerts K, De Bock PJ, Swerts J, Vilain S et al (2014) PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling. Science 344:203–207. doi:10.1126/science.1249161
26. Osterwalder T, Yoon KS, White BH, Keshishian H (2001) A conditional tissue-specific transgene expression system using inducible GAL4. Proc Natl Acad Sci USA 98:12596–12601. doi:10.1073/pnas.221303298
27. Parvathy S, Davies P, Haroutunian V, Purohit DP, Davis KL, Mohs RC et al (2001) Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline. Arch Neurol 58:2025–2032
28. Rogers I, Kerr F, Martinez P, Hardy J, Lovestone S, Partridge L (2012) Ageing increases vulnerability to abeta42 toxicity in Drosophila. PLoS One 7:e40569. doi:10.1371/journal.pone.0040569
29. Saito T, Suemoto T, Brouwers N, Sleegers K, Funamoto S, Mihira N et al (2011) Potent amyloidogenicity and pathogenicity of Abeta43. Nat Neurosci 14:1023–1032. doi:10.1038/nn.2858
30. Sandebring A, Welander H, Winblad B, Graff C, Tjernberg LO (2013) The pathogenic abeta43 is enriched in familial and sporadic Alzheimer disease. PLoS One 8:e55847. doi:10.1371/journal.pone.0055847
31. Seither KM, McMahon HA, Singh N, Wang H, Cushman-Nick M, Montalvo GL et al (2014) Specific aromatic foldamers potently inhibit spontaneous and seeded Abeta42 and Abeta43 fibril assembly. Biochem J. doi:10.1042/BJ20131609
32. Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81:741–766
33. Sofola O, Kerr F, Rogers I, Killick R, Augustin H, Gandy C et al (2010) Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer’s disease. PLoS Genet 6:e1001087. doi:10.1371/journal.pgen.1001087
34. Speretta E, Jahn TR, Tartaglia GG, Favrin G, Barros TP, Imarisio S et al (2012) Expression in Drosophila of tandem amyloid beta peptides provides insights into links between aggregation and neurotoxicity. J Biol Chem 287:20748–20754. doi:10.1074/jbc.M112.350124
35. Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL et al (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413:739–743. doi:10.1038/35099568
36. Welander H, Franberg J, Graff C, Sundstrom E, Winblad B, Tjernberg LO (2009) Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains. J Neurochem 110:697–706. doi:10.1111/j.1471-4159.2009.06170.x
37. Younkin SG (1998) The role of A beta 42 in Alzheimer’s disease. J Physiol Paris 92:289–292
38. Zou K, Liu J, Watanabe A, Hiraga S, Liu S, Tanabe C et al (2013) Abeta43 is the earliest-depositing Abeta species in APP transgenic mouse brain and is converted to Abeta41 by two active domains of ACE. Am J Pathol 182:2322–2331. doi:10.1016/j.ajpath.2013.01.053